For your skin
Highly biocompatible "cellular messengers" that literally tell your skin cells to stop panicking and start repairing. Excellent for severe redness and compromised barriers.
Want the science? Keep reading ↓Mechanism of action
Nano-sized signaling vesicles derived from plant cells (primarily Centella Asiatica) that act as intercellular messengers to suppress inflammatory cytokines (IL-6, TNF-alpha) and accelerate tissue repair.
Why we tier this anecdotal
4 cited papers across 2 countries. Most of what's cited here is mechanism-level or in-vitro work. We track this as Anecdotal until controlled clinical trials accumulate.
Cited research
Cho BS et al., Characterization of Rosa damascena Callus-Derived Exosome-like Vesicles and Their Multifunctional Activities in Skin-Related Cellular Models, International Journal of Molecular Sciences 2026
Park HS, Shin S, Clinical Efficacy and Safety Evaluation of a Centella asiatica (CICA)-Derived Extracellular Vesicle Formulation for Anti-Aging Skincare, Cosmetics 2025;12(4):135 — two-week human instrumental study of a topical CICA-EV ampoule: mean pore area -17.9%, pore density -26.9%, surface roughness -9.0%; 24h patch test on 30 subjects non-irritating
Chang TM, Wu CC, Huang HC, Wang SS, Chuang CH, Kao PL, Tang WH, Liu LT, Qiu WY, Percec I, Chen C, Kuo TY, In Vitro Characterization of Centella asiatica Extracellular Vesicles and Their Skin Repair Effects in a UVB-Irradiated Mouse Model, International Journal of Molecular Sciences 2025 — in-vitro + mouse model: Centella-derived EVs upregulated collagen (COL1A1) and reduced UVB damage markers; molecular/animal mechanism, not a human efficacy trial
Lee Y et al., Safety Profile of Solanum tuberosum-Derived Exosomes: Evidence from In Vitro Experiments and Human Skin Tests, Pharmaceuticals (Basel) 2025
Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.